日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Biological Signatures of Inflammation Biomarkers Identified Using Data Reduction Methods in Adult Population: A Scoping Review Protocol

利用数据简化方法在成人人群中识别炎症生物标志物的生物学特征：范围界定综述方案

期刊:Biomarker Insights
影响因子:2.6
doi:10.1177/11772719221078774
Qureshi, Sadaf; Chan, Nancy; George, Mridula; Ganesan, Shridar; Toppmeyer, Deborah; Omene, Coral; Sánchez‐Gordón, Gary; Plans‐Beriso, Elena; Barahona‐López, Cristina; Anta, Berta; Millet, Oscar; Fernández‐Navarro, Pablo; Fernández de Larrea‐Baz, Nerea; Castelló‐Pastor, Adela
炎症/感染
Immunology/Inflammation
炎症
发表日期：2026
文献求助 收藏

Monoallelic expression characterizes a distinct molecular and clinical group of breast tumors

单等位基因表达是乳腺肿瘤分子和临床特征的一个独特类别。

期刊:
影响因子:
doi:10.21203/rs.3.rs-8535132/v1
Arabzadeh, Mona; Singh, Amartya; Payne, Kyle; Ganesan, Shridar; Khiabanian, Hossein
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Immune Checkpoint Blockade Delays Cancer Development and Extends Survival in DNA Polymerase Mutator Syndromes.

免疫检查点阻断可延缓癌症发展并延长DNA聚合酶突变综合征患者的生存期

期刊:Cancer Research
影响因子:16.6
doi:10.1158/0008-5472.CAN-24-2589
Sawant Akshada, Shi Fuqian, Cararo Lopes Eduardo, Hu Zhixian, Abdelfattah Somer, Baul Jennele, Powers Jesse R, Hinrichs Christian S, Rabinowitz Joshua D, Chan Chang S, Lattime Edmund C, Ganesan Shridar, White Eileen P
免疫/内分泌
发表日期：2025
文献求助 收藏

Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors

实体瘤内的多细胞免疫生态型可预测免疫检查点抑制剂在现实世界中的治疗效果

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-65016-3
Wang, Xuefeng; Li, Tingyi; Eljilany, Islam; Soupir, Alex; Radmacher, Michael; Agius, Phaedra; Sukrithan, Vineeth; Ratan, Aakrosh; McCarter, Martin; Salhia, Bodour; Colman, Howard; Naqash, Abdul R; Puzanov, Igor; Arnold, Susanne; Marin-Acevedo, Julian A; Ganesan, Shridar; Churchman, Michelle; Hwu, Patrick; Rodriguez, Paulo C; Dalton, William S; Weiner, George J; Tarhini, Ahmad A
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Respiration defects limit serine synthesis required for lung cancer growth and survival.

呼吸缺陷会限制肺癌生长和存活所需的丝氨酸合成

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-62911-7
Cararo Lopes Eduardo, Shi Fuqian, Sawant Akshada, Ibrahim Maria, Gomez-Jenkins Maria, Hu Zhixian, Manchiraju Pranav, Bhatt Vrushank, Wang Wenping, Hinrichs Christian S, Wallace Douglas C, Su Xiaoyang, Rabinowitz Joshua D, Chan Chang S, Guo Jessie Yanxiang, Ganesan Shridar, Lattime Edmund C, White Eileen
肿瘤
肺癌
发表日期：2025
文献求助 收藏

Subtype-Specific mRNA Signatures of Human Ribosomal Proteins in Pediatric Cancers

儿童癌症中人类核糖体蛋白的亚型特异性mRNA特征

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms262412036
Panda, Anshuman; Yadav, Anupama; Bhanot, Gyan; Ganesan, Shridar
Human
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Targeting c-MET Alterations in Cancer: A Review of Genetic Drivers and Therapeutic Implications

靶向c-MET改变治疗癌症：遗传驱动因素和治疗意义综述

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17091493
Ji, Michelle; Ganesan, Shridar; Xia, Bing; Huo, Yanying
肿瘤
MET
肿瘤免疫
发表日期：2025
文献求助 收藏

Differences in COVID-19-Related Hospitalization, Treatment, Complications, and Death by Race and Ethnicity and Area-Level Measures Among Individuals with Cancer in the ASCO Registry

ASCO登记的癌症患者中，COVID-19相关住院、治疗、并发症和死亡的种族、民族和地区差异

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17050857
Ashrafi, Adiba; Lin, Yong; Fong, Angela J; Islam, Jessica Y; Anderson, Tiffany C Turner; Ganesan, Shridar; Heckman, Carolyn J; Llanos, Adana A M
ASC
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Clonal Hematopoiesis Dynamics and Evolutionary Fitness During Cancer Treatment Impact Clinical Outcomes

癌症治疗期间克隆性造血动力学和进化适应性影响临床结果

期刊:
影响因子:
doi:10.1101/2025.08.27.25334581
Arabzadeh, Mona; Tang, Yi-Han; Colin-Leitzinger, Christelle; Marzban, Sadegh; Walgenbach, Daniel; Morganti, Stefania; Mahaganapathy, Vaidhyanathan; Harper, Erika; Teng, Mingxiang; Kresovich, Jacob K; Washington, Iman; Parsons, Heather A; Garber, Judy E; West, Jeffrey; Ganesan, Shridar; Khiabanian, Hossein; Gillis, Nancy
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC

以机制为中心的调控网络将 NME2 和 MYC 程序确定为 CRPC 中恩杂鲁胺耐药的标志

期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-024-44686-5
Sukanya Panja #, Mihai Ioan Truica #, Christina Y Yu, Vamshi Saggurthi, Michael W Craige, Katie Whitehead, Mayra V Tuiche, Aymen Al-Saadi, Riddhi Vyas, Shridar Ganesan, Suril Gohel, Frederick Coffman, James S Parrott, Songhua Quan, Shantenu Jha, Isaac Kim, Edward Schaeffer, Vishal Kothari, Sarki A A
信号转导
发表日期：2024
文献求助 收藏